Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Expression of CLDN1 in colorectal cancer: a novel marker for prognosis.

Expression of CLDN1 in colorectal cancer: a novel marker for prognosis. Int J Oncol. 2011 Oct; 39(4):791-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.